Generation 1
CNT Electrode
Direct electrochemical nucleic acid sensing using carbon nanotube structures.
Solved: proof of direct signal generation
Remaining constraint: variability
⭐ The Origin of the Nano-Bio-Info Scaling Law
Converging nanotechnology, biology, and information systems
The foundation of a new architecture for biological measurement.
Guanine did not begin as a single assay or product. It emerged through a progression of inventions at the intersection of nanotechnology, biological detection, and signal processing—each designed to remove a fundamental constraint in biological measurement.
Across multiple generations of technology, the same pattern appeared: sensitivity improved but complexity increased, multiplexing expanded but stability weakened, and new analytes required entirely new systems.
The result of that progression was not another assay. It was a programmable measurement architecture built from the convergence of nano, bio, and information systems.
⭐ A Convergence, Not a Single Invention
Each generation solved a problem—and revealed a deeper one
The platform evolved by systematically removing core measurement constraints rather than optimizing a single component in isolation.
This is the origin of the Nano-Bio-Info Scaling Law: measurement capability expands when biological information can be generated, stabilized, amplified, encoded, and interpreted within a shared system.
Guanine’s architecture was shaped by that logic from the beginning.
Each generation removed a core limitation, culminating in a software-defined sensing architecture.
⭐ The Deep-Tech Journey
From direct signal generation to programmable measurement
The path from early CNT sensing to the current platform was defined by successive attempts to solve what existing systems could not.
Generation 2
Structured CNT Electrode
Ordered nanotube placement to improve consistency of direct signal output.
Solved: reduced variability
Remaining constraint: cost and manufacturing complexity
Generation 3
ssOligo Tag
Cross-analyte signal tagging to move beyond direct-detection-only systems.
Solved: broader analyte reach
Remaining constraint: instability
Generation 4
Quadruplex Oligo Tag
Reversible oligonucleotide signal generation through a synthetic nanomaterial primitive.
Solved: reversible signal behavior
Remaining constraint: low sensitivity at low concentration
Generation 5
Signal Amplification
High-density signal amplification through dense quadruplex loading on magnetic particles.
Solved: stronger detectable signal
Remaining constraint: multiplex and real-sample complexity
Generation 6
MDWC + CME
Adaptive waveform control and composite encoding integrated into a programmable signal architecture.
Result: stable, multiplexed, low-concentration, software-defined biological measurement
⭐ Why the Nano-Bio-Info Convergence Matters
The platform did not emerge from one assay need
It emerged from repeated attempts to solve the same measurement limitation across nanomaterials, biological sensing, and signal processing.
That is why the resulting system is broader than a single diagnostic workflow. The same convergence that produced the core architecture now supports the other pages of the site:
- Technology explains how the architecture works
- Sepsis shows how it solves a time-critical clinical problem
- OEM Platform shows how it scales across assay developers and markets
- Investors shows how that architecture compounds into platform economics and defensibility
The About page exists to explain why this platform exists at all.
The Core Insight
Biology is sparse, dynamic, and multi-dimensional. Most systems were built for abundant, isolated, and static signals.
Guanine emerged by repeatedly solving that mismatch—until a unified architecture became possible.
⭐ Our Founder
Building Measurement Infrastructure
Neil Gordon
President, Founder, Inventor
B.Eng., MBA
Neil Gordon is the inventor of Guanine’s software-defined electrochemical sensing architecture and founder of Guanine Inc and its predecessor, Early Warning Inc, a NASA spin-off.
His early work in nanotechnology focused on how nanoscale materials interface with biological systems—not just for detection, but for signal generation and control. Through collaborations spanning Taiwan’s ITRI, Canada’s NRC, and the NASA-led CANEUS Consortium, he worked at the intersection of biology, semiconductors, and advanced sensing systems.
This led to a central insight: the primary limitation in biological measurement is architectural, not biological.
He subsequently led a sensing spin-out from NASA that evolved into Guanine’s core platform. Incubation within Mount Sinai’s Elementa Labs helped define initial clinical applications in sepsis, alongside broader OEM deployment opportunities.
Guanine is built on a software-defined architecture for biological measurement.
⭐ Founder Thesis
From nanotechnology to programmable biological measurement
Cross-domain foundation
Nanotechnology, biology, semiconductors, and electrochemical sensing.
Core insight
Biological measurement has been constrained by system architecture rather than biology alone.
Platform outcome
A software-defined electrochemical architecture designed for clinical and OEM scale.